Fall Learning Series: Nutrition, Type 2 Diabetes and Chronic Kidney Disease

October 09, 2021

10:00 am CDT -1:00 pm CDT

Register

Join us for a complimentary educational event this fall, where you can network with colleagues, earn 2.0 CE contact hours, including 0.75 pharmacology, and learn more about PCNA. Hosted by the Arizona, Central California, Northern California, and Rocky Mountain PCNA Chapters.

PCNA members and non-members are welcome to register and attend. Please share this with colleagues and friends. Learn more about our other Fall Learning Series events.

Agenda

10:00 am  CT – Welcome and Introduction
10:15 am CT – Cardiovascular Risk Factors, Ethnic Disparities, Covid-19 Mortality and Nutrition (1.0 CE) – Dr. Williams
11:15 am CT – Treating Patients with Type 2 Diabetes and Chronic Kidney Disease (1.0 CE, including 0.75 pharmacology) – Susie Livingston, NP
12:15 pm CT – Closing

Presentation Topics

Cardiovascular Risk Factors, Ethnic Disparities, Covid-19 Mortality and Nutrition (1.0 CE )

Learning Objectives
  • Explain the relationship between nutrients and death from heart disease.
  • Examine the effect of diet on risk factors for heart attack, stroke, hypertension, diabetes, obesity and death.
  • Relate the changes in coronary plaque occurring with a plant-based diet.
  • Summarize the long-term effects of a plant-based diet.
  • Describe the excess cardiovascular mortality in African Americans, based on nutrition-related risk factors and disease
  • Discuss the risk factors for poor outcomes with COVID-19: obesity, diabetes mellitus, hypertension and cardiovascular disease, resulting in poorer outcomes in African Americans.

Treating Patients with Type 2 Diabetes and Chronic Kidney Disease (1.0 CE, including 0.5 pharmacology )

Learning Objectives
  • Describe the risk of cardiovascular and renal complications in patients with T2D.
  • Review the effect of cardiovascular medications on renal function in patients with T2D. 3
  • Discuss evidence-based treatment strategies to maximize patient outcomes for those with T2D, heart failure, and CKD.
  • Examine emerging trends in treatment strategies for T2D concerning COVID-19.
Relevant PCNA Patient Education
Register